BioPharma Dive Mar 18, 2026 J&J wins FDA nod for psoriasis pill that aims to compete with top-selling injections
BioPharma Dive Mar 18, 2026 Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers
BioPharma Dive Mar 16, 2026 Sarepta tests new Elevidys safeguards; Sana advances diabetes cell therapy
BioPharma Dive Mar 13, 2026 With FDA go ahead, a China biotech notches a first in cell therapy testing
BioPharma Dive Mar 12, 2026 Lilly warns GLP-1 knockoffs may be ‘dangerous,’ escalating war with compounders